Satellos Bioscience Inc. (MSLE) vs Senti Biosciences, Inc. (SNTI)
A side-by-side comparison of Satellos Bioscience Inc. and Senti Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MSLE
Satellos Bioscience Inc.
$8.08HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT
SNTI
Senti Biosciences, Inc.
$0.32HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT
Total return — MSLE vs SNTI
growth of $100 · dividends reinvested · last 1yMSLE +13.7% (+13.7%/yr)SNTI -69.2% (-69.2%/yr)MSLE compounded faster over this window
MSLE SNTI
MSLE vs SNTI: by the numbers
- •MSLE is the larger company ($10M vs $10M market cap).
- •Both run net losses; MSLE's is the smaller (0.00% vs -90116.36% net margin).
Metrics side by side
Valuation
| Metric | MSLE | SNTI |
|---|---|---|
| P/S ratio | N/A | 182.06 |
| P/B ratio | 0.17 | N/A |
Profitability
| Metric | MSLE | SNTI |
|---|---|---|
| Gross margin | 0.00% | -16431.82% |
| Operating margin | 0.00% | -289668.18% |
| Net margin | 0.00% | -90116.36% |
| ROE | -57.34% | N/A |
| ROIC | -59.35% | -227.67% |
Growth (annualized)
| Metric | MSLE | SNTI |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -43.85% |
| Total return CAGR (5Y) | N/A | -67.75% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.